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Protein serine/threonine 
phosphatase PPEF-1 suppresses 
genotoxic stress response via 
dephosphorylation of PDCD5
Soo-Yeon Park1,*, Jaesung Seo1,*, Hyo-Kyoung Choi2,*, Hye-Jeong Oh1, Garam Guk1, 
 Yoo-Hyun Lee3, Jeongmin Lee4, Woo Jin Jun5, Kyung-Chul Choi6 & Ho-Geun Yoon1
Programmed cell death 5 (PDCD5) is believed to play a crucial role in p53 activation; however, the 
underlying mechanism of how PDCD5 function is regulated during apoptosis remains obscure. Here, 
we report that the serine/threonine phosphatase PPEF-1 interacts with and dephosphorylates PDCD5 
at Ser-119, which leads to PDCD5 destabilization. Overexpression of wild-type PPEF-1, but not 
inactive PPEF-1D172N, efficiently suppressed CK2α-mediated stabilization of PDCD5 and p53-mediated 
apoptosis in response to etoposide (ET). Conversely, PPEF-1 knockdown further enhanced genotoxic 
stress responses. Notably, PPEF-1 suppressed p53-mediated genotoxic stress response via negative 
regulation of PDCD5. We also determined that overexpression of wild-type PPEF-1, but not inactive 
PPEF-1D172N, significantly increased tumorigenic growth and chemoresistance of A549 human lung 
carcinoma cells. Collectively, these data demonstrate that PPEF-1 plays a pivotal role in tumorigenesis 
of lung cancer cells by reducing PDCD5-mediated genotoxic stress responses.
Coordinated regulation of cell death is crucial for the maintenance of cellular homeostasis1. Aberrant regulation of 
cell death is believed to lead to the development of multiple diseases such as neurodegeneration, immune deficiency, 
infertility, and cancer2. It is well known that p53 is a key executioner of cellular apoptosis regulation3. In unstressed 
conditions, the p53 protein is degraded by MDM2. In response to cellular stress, such as DNA damage, oxida-
tive stress, and hypoxia, p53 rapidly accumulates in the nucleus and undergoes posttranslational modifications4, 
then becomes activated by interacting proteins such as ASPPs, Brn-3b, NF-kB/p52, and Muc1, leading to an 
increase in cellular apoptosis5–8. Programmed cell death 5 (PDCD5) associates with p53 in response to DNA 
damage and stabilizes p53 by inhibiting the interaction between MDM2 and p539. PDCD5 also binds to and 
activates the histone acetyltransferase Tip60, which promotes DNA damage responses10. PDCD5 also participates 
in the release of cytochrome C by mediating the translocation of cytosolic Bax to the mitochondria11. PDCD5 
downregulation has been reported in multiple human cancers due to its anti-apoptotic activity2,12–14. Despite 
the crucial role of PDCD5 in p53 activation and apoptosis, the factors and mechanisms involved in modulating 
PDCD5 function have not been elucidated. Casein kinase 2 was recently shown to phosphorylate PDCD5 at Ser-
199 in vitro10. That study showed that overexpression of the phosphor-PDCD5 mutant, which replaced Ser-119 
with alanine, failed to increase p53 activity, suggesting that CK2 positively affected PDCD5 function via Ser-119 
phosphorylation. More recently, our group reported that CK2-dependent phosphorylation enhanced the stabili-
zation and nuclear localization of PDCD5, which leads to p53-mediated genotoxic stress responses15. However, it 
is unclear how PDCD5 phosphorylation is regulated during genotoxic stress responses.
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Accumulating evidence indicates that reversible protein phosphorylation is executed by kinases and 
phosphatases16. For example, the PDCD5-interacting protein p53 is phosphorylated at Ser-15 by ATM and this 
phosphorylation is removed by p53-induced phosphatase 1 (Wip1), which consequently prevents p53-dependent 
G2 arrest17. DUSP26 inhibits doxorubicin-induced p53 phosphorylation at Ser-20 and Ser-37, and consequently 
inhibits p53-mediated downstream activity18. Similar to p53, PDCD5 rapidly accumulates in the nucleus and is 
associated with the p53 response to genotoxic stress19. A recent study suggests that the phosphorylation status 
of PDCD5 affects it pro-apoptotic function10. In agreement with these reports, we found that CK2 knockdown 
diminished the levels of PDCD5 and phosphorylated PDCD5, and reduced p53 activation in response to etopo-
side (ET)15. This raises the possibility that PDCD5 function could be negatively regulated by dephosphorylation; 
however, the phosphatase that regulates PDCD5 phosphorylation has not been identified.
Here, we report that the protein serine/threonine phosphatase PPEF-1 binds to PDCD5 and reduces its 
phosphorylation at Ser-119, which consequently inhibits p53-mediated apoptosis. We show that PPEF-1 over-
expression significantly enhances tumor growth and chemoresistance of A549 cells. Our results identify the 
molecular mechanism by which PPEF-1 negatively regulates the pro-apoptotic function of PDCD5 via PDCD5 
dephosphorylation.
Results
Protein serine/threonine phosphatase PPEF-1 binds to and dephosphorylates PDCD5 at Ser-119. 
We recently showed that PDCD5 phosphorylation at Ser-119 is rapidly induced by the genotoxic stress response, 
which stabilizes the protein and results in PDCD5 nuclear translocation15. PDCD5 phosphorylation is main-
tained at a low level in the absence of genotoxic stress. It is believed that protein phosphorylation is reversibly 
regulated by kinases and phosphatases16. Therefore, we examined whether a specific phosphatase dephospho-
rylates PDCD5 at Ser-119. First, we screened for the phosphatase that interacts with PDCD5. We generated 
a library of mammalian expression vectors that encode 12 serine/threonine phosphatases, including 6 protein 
phosphatases (PPPs), 5 metal-dependent protein phosphatases (PPMs) and protein phosphatase with EF-hand 
domain 1(PPEF-1). We co-transfected PDCD5 and various phosphatases into the human colorectal carcinoma 
cell line HCT116, and analyzed the associations of PDCD5 with these phosphatases by immunoprecipitation 
using antibody against Myc. Four phosphatases, including PPEF-1, PPP1CA, PPP6C, and PPPM1K, strongly 
interacted with Myc-PDCD5 (Fig. 1a). PPEF-1 overexpression specifically reduced PDCD5 phosphorylation at 
Ser-119 and PDCD5 protein level. Consequently, PPEF-1 also reduced the level of p53 (Fig. 1b). GST pull-down 
analysis showed that PPEF-1 directly interacted with PDCD5. Mapping analysis demonstrated that the domain 
1 region, including the IQ domain of PPEF-1 (residues 1–30), directly interacted with PDCD5 (Fig. 1c). Next, 
we examined the PPEF-1-binding region in PDCD5. Co-immunoprecipitation analysis showed that the PDCD5 
N-terminal domain (residues 1–30) interacted with PPEF-1 (Fig. 1d). These data suggest that PPEF-1binds to and 
dephosphorylates PDCD5 at Ser-119 during the genotoxic stress response.
PPEF-1 suppresses etoposide-induced PDCD5 phosphorylation and stabilization. We found 
that PPEF-1 directly bound to and dephosphorylated PDCD5. Next, we investigated whether PPEF-1 reduced 
PDCD5 stabilization via the ubiquitin-dependent proteosomal pathway. Treatment with MG132 significantly 
increased PDCD5 levels, whereas PPEF-1 overexpression diminished the effect of MG132 on PDCD5 stabili-
zation (Fig. 2a). A cycloheximide time-course experiment showed that PPEF-1 overexpression further reduced 
PDCD5 stability when compared with that of the control (Fig. 2b). We next examined the effect of PPEF-1 knock-
down on PDCD5 stability using siRNAs designed for PPEF-1. The specific knockdown efficiency of each siRNA 
was established by western blotting and quantitative RT-PCR analysis (Fig. 2c–e). Then, we examined the change 
in PDCD5 mRNA levels in A549 cells after treatment with the siRNAs for PPEF-1. PPEF-1 knockdown reduced 
PPEF-1 mRNA levels, but did not reduce PDCD5 mRNA levels, and PPEF-1 overexpression did not affect PDCD5 
mRNA levels (Fig. 2d). Consistently, PPEF-1 knockdown significantly increased PDCD5 stability when compared 
with the effect of cycloheximide treatment alone, which indicates a crucial role for PPEF-1 in PDCD5 destabi-
lization (Fig. 2c) PPEF-1 knockdown enhanced the phosphorylation and stabilization of endogenous PDCD5 
(Fig. 2e). These results demonstrate that PPEF-1 reduces PDCD5 stability via PDCD5 dephosphorylation.
Next, we investigated whether PPEF-1 phosphatase activity is required for the reduction of PDCD5 phos-
phorylation and stabilization by generating PPEF-1 mutants in which the catalytic domain residues are replaced 
with alternative amino acid residues; we, then, tested for phosphatase activity. As expected, overexpression of 
wild-type PPEF-1 efficiently reduced the phosphorylation and stabilization of PDCD5. However, overexpres-
sion of the inactive mutant PPEF-1D172N had negligible effects on the phosphorylation and stability of PDCD5 
when compared with that of other PDCD5 mutants (Fig. 2f). We recently reported that the stability of PDCD5 
is regulated via the ubiquitin-dependent proteasomal degradation pathway15. We examined the effect of PPEF-1 
overexpression on changes in PDCD5 ubiquitination. Wild-type PPEF-1 overexpression dramatically increased 
PDCD5 ubiquitination; however, overexpression of inactive PPEF-1D172N had a negligible effect on PDCD5 ubiq-
uitination and stability (Fig. 2g). These combined results suggest that PPEF-1 dephosphorylates PDCD5, which 
leads to protein degradation via the ubiquitin-dependent proteasomal degradation pathway.
PPEF-1 antagonizes CK2-mediated PDCD5 stabilization in response to genotoxic stress. 
CK2-dependent phosphorylation enhanced PDCD5 stability and nuclear localization in response to genotoxic 
stress15. ET treatment rapidly induced nuclear accumulation of PDCD5, which was consistent with the result of a 
previous study10. Wild-type PPEF-1 completely abrogated PDCD5 stabilization in response to ET. However, the 
inactive PPEF-1D172N mutant failed to block accumulation of PDCD5 in the nucleus, indicating that PPEF-1 has a 
crucial role in negative regulation of PDCD5 function (Fig. 3a).
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We previously reported that CK2 phosphorylated PDCD5 at Ser-119, and thereby positively regulated its func-
tion. Next, we examined whether PPEF-1 antagonized CK2 activity and affected PDCD5 stability and phosphoryl-
ation. CK2 overexpression significantly increased PDCD5 phosphorylation and stability; however, overexpression 
of wild-type PPEF-1 efficiently reversed CK2-mediated PDCD5 phosphorylation and stability. By contrast, the 
inactive PPEF-1D172N mutant failed to antagonize CK2-mediated PDCD5 phosphorylation and stability (Fig. 3b). 
Overexpression of wild-type PPEF-1, but not mutant PPEF-1D172N, dramatically increased PDCD5 ubiquitination 
(Fig. 3c). These combined results indicate that PPEF-1 antagonizes CK2 action on PDCD5 stabilization.
Figure 1. The protein serine/threonine phosphatase PPEF-1 binds to and dephosphorylates Ser-119 of 
PDCD5. (a) PDCD5 interacts with PPEF-1, PPP1CA, PPP6C, and PPM1K. Myc-tagged PDCD5 and Flag-tagged 
phosphatases were co-transfected into HCT116 (p53+/+) cells. Whole-cell lysates were immunoprecipitated and 
immunoblotted with the indicated antibodies. (b) PPEF-1 selectively dephosphorylates PDCD5 at Ser-119. Cell 
lysates were immunoblotted with the indicated antibodies. (c) The IQ motif domain of PPEF-1 interacts with 
PDCD5. Schematic diagrams of Myc-tagged PPEF-1 for GST pull-down analysis. Bound proteins were eluted 
and analyzed using autoradiography. (d) The N-terminal domain of PDCD5 (residues 1–30) interacts with PPEF-
1. Schematic diagrams of Myc-tagged PDCD5 for co-immunoprecipitation and mapping analysis. HCT116 
(p53+/+) cells were cotransfected with the indicated Myc-PDCD5 and Flag-PPEF-1 plasmids. Cell lysates were 
immunoprecipitated with Flag antibodies, and subsequently immunoblotted with the indicated antibodies. Full-
length blots are presented in Supplementary Figure 1a-d.
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Figure 2. PPEF-1 dephosphorylates PDCD5, which causes protein destabilization via the ubiquitin-
dependent proteasomal degradation pathway. (a) PPEF-1 overexpression blocks the effect of MG132 on 
PDCD5 stabilization. HCT116 cells were transfected with Flag-tagged PPEF-1. Two days after transfection, 
cells were treated with MG132 (10 μ M) for 6 h. Total lysates were immunoblotted with the indicated antibodies. 
(b,c) PPEF-1 reduces the stability of PDCD5 protein. HCT116 cells were transfected with either Flag-
PPEF-1 or si-PPEF1, cells were treated with 10 μ g/mL cycloheximide (CHX) for the indicated times, and 
then immunoblotted with the indicated antibodies. (d) PPEF-1 does not affect the mRNA level of PDCD5. 
A549 cells were transfected with either Flag-PPEF-1 or si-PPEF1, and qRT-PCR analyses were performed 
to measure PDCD5 mRNA expression levels. *P < 0.05 versus control. (e) PPEF-1 knockdown increases 
PDCD5 phosphorylation. Cells were harvested and immunoblotted 48 h after siRNA transfection. (f) Inactive 
PPEF-1D172N mutant does not affect PDCD5 Ser-119 phosphorylation. Forty-eight hours after transfection, 
cells were treated with 50 μ M etoposide (ET) for 2 h and then harvested. Cell lysates were immunoblotted 
with the indicated antibodies. (g) PPEF-1 overexpression increases PDCD5 ubiquitination. HCT116 cells 
were transfected with HA-tagged ubiquitin, Flag-tagged PPEF-1, Flag-tagged PPEF-1D172N, or Myc-tagged 
PDCD5 as indicated. Cells were treated with MG132 (10 μ M) for 6 h before harvesting. Total cell extracts were 
immunoprecipitated using the Myc antibody and immunoblotted with the HA antibody. Full-length blots are 
presented in Supplementary Figure 2a-g.
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Figure 3. PPEF-1 antagonizes CK2 action on PDCD5 stabilization. (a) PPEF-1 overexpression induced 
PDCD5 degradation, but the inactive PPEF-1D172N mutant did not affect ET-induced stabilization. A549 cells 
were transfected with the indicated constructs, and then treated with ET for 6 h. Fixed cells were stained with 
the indicated immunofluorescent antibodies. Bar scale = 10 μ m (b) Active PPEF-1, but not the inactive PPEF-
1D172N mutant, antagonizes CK2-induced PDCD5 stabilization. A549 cells were transfected with Myc-CK2α 
or Flag-PPEF-1 as indicated. Total cell extracts were immunoblotted with the indicated antibodies. (c) Inactive 
PPEF-1D172N, but not wild-type PPEF-1, fails to antagonize CK2-induced reduction of PDCD5 ubiquitination. 
HCT116 cells were transfected with HA-tagged ubiquitin, Myc-tagged CK2, PPEF-1, PPEF-1D172N, or Flag-
tagged PDCD5 as indicated. Cells were treated with MG132 (10 μ M) for 6 h before harvesting. Total cell extracts 
were immunoprecipitated using Myc antibody and immunoblotted with HA antibody. Full-length blots are 
presented in Supplementary Figure 3b-c.
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PPEF-1 inhibits p53-mediated genotoxic stress response via negative regulation of PDCD5. 
PDCD5 was identified as a positive regulator of p53-mediated apoptosis. Therefore, we examined the role of 
PPEF-1 on p53-mediated apoptosis signaling. PPEF-1 overexpression efficiently blocked p53 activation and tran-
scriptional activation of pro-apoptotic genes in response to ET (Fig. 4a,b). However, the inactive PPEF-1D172N 
mutant did not affect ET-induced p53 activation (Fig. 4c), and PPEF-1 knockdown significantly enhanced p53 
activation in response to ET. These results indicate that PPEF-1 is a negative regulator of p53-mediated apoptosis 
(Fig. 4d).
We previously showed that PDCD5 is required for p53-mediated genotoxic stress response signaling. 
Therefore, we examined whether PPEF-1 inhibited p53 activation via PDCD5. Consistently, PPEF-1 knockdown 
substantially increased PDCD5 stability, phosphorylation, and p53 activation in mouse embryonic fibroblasts 
(MEFs). However, depletion of PDCD5 by treating PDCD5flox/flox MEFs with Cre recombinase (Ad-Cre) express-
ing adenovirus blocked the effect of PPEF-1 knockdown on p53 activation (Fig. 4e). These results indicate that 
PPEF-1 suppresses p53 activation via negative regulation of PDCD5.
Overexpression of PPEF-1 confers chemoresistance in human A549 lung cancer cells. To inves-
tigate the functional role of PPEF-1 in genotoxic stress-induced apoptosis, we performed MTT and TUNEL 
assays in A549 lung cancer cells after overexpression of wild-type PPEF-1 or inactive PPEF-1D172N mutant. ET 
treatment increased DNA damage and cancer cell death, whereas PPEF-1 overexpression dramatically sup-
pressed the ET-induced DNA damage response and cell death. However, the inactive PPEF-11D172N mutant failed 
to suppress the DNA damage response and cancer cell death (Fig. 5a,b, left panel). PPEF-1 knockdown further 
increased the ET-induced apoptosis and cell death, demonstrating the negative regulatory function of PPEF-1 on 
cellular apoptosis (Fig. 5a,b, right panel). Given the critical role of PPEF-1 in blocking cell death in A549 cells, we 
next examined whether PPEF-1 overexpression increased in vivo chemoresistance of A549 cells. To this end, we 
generated stable A549 cell lines expressing wild-type PPEF-1 or mutant PPEF-1D172N and performed xenograft 
assays using subcutaneous injections of the stable A549 cell lines into nude mice. The results showed that over-
expression of wild-type PPEF-1 significantly increased the tumorigenic growth and chemoresistance of A549 
cells compared with that of control cells. Strikingly, overexpression of the inactive PPEF-1D172N mutant had only 
a negligible effect on chemoresistance of A549 cells (Fig. 5c). These results indicate that PPEF-1 overexpression 
enhances the chemoresistance of A549 lung cancer cells by reducing the genotoxic stress response.
Discussion
PDCD5 is a positive regulator of p53 during the DNA damage response, and CK2 increases the levels of PDCD5 
phosphorylation and stability. CK2-mediated phosphorylation of PDCD5 at Ser-119 is responsible for PDCD5 
nuclear translocation in response to genotoxic stress, which correlates with p53 activation. These combined 
results indicate that CK2 positively enhances p53-mediated apoptosis via phosphorylation of PDCD5 at Ser-119. 
PDCD5 protein is maintained at a low level in the absence of genotoxic stress response, similar to p53; therefore, 
the dephosphorylation status of PDCD5 is likely mediated by a phosphatase that destabilizes PDCD5.
PPEF-1 function has only been partially described as involved in apoptosis in human cells. PPEF-1 was initially 
found to participate in the differentiation of sensory neurons, and was highly similar to Drosophila retinal degen-
eration C (RdgC)20. Loss-of-function studies of the RdgC gene increased light-dependent photoreceptor apoptosis 
in Drosophila21. This result is consistent with our finding that PPEF-1 suppresses apoptosis in response to gen-
otoxic stress. PPEF-1 possesses three EF-hand motifs at the C-terminus, suggesting a role of PPEF-1 in calcium 
regulatory responses22. Calcium ion is an important second messenger that controls cell death responses. Calcium 
release from the endoplasmic reticulum to the cytosol is a requisite for apoptosis23. Changes in the cytosolic 
calcium level are associated with T-cell lymphoma24. PPEF-1 transcript is strongly expressed in the T-cell lymph-
oblastic lymphoma cell line, suggesting a plausible role in the development of T-cell lymphoblastic lymphoma25. 
Therefore, it would be interesting to determine whether PPEF-1 modulates calcium-induced apoptosis via negative 
regulation of PDCD5 in T-cell lymphoblastic lymphoma cell.
Here, we identified four phosphatases, PPEF-1, PPP1CA, PPP6C, and PPM1K as PDCD5 interacting mole-
cules among 12 phosphatases, and we found that only PPEF-1 dephosphorylates PDCD5 at Ser-119, which leads 
to protein destabilization via the ubiquitin-dependent proteosomal degradation pathway. PPEF-1 efficiently sup-
presses the p53-mediated genotoxic stress response. Notably, we did not observe the anti-p53 action of PPEF-1 in 
the depletion of PDCD5. This suggests that PPEF-1 suppresses p53 activation via dephosphorylation of PDCD5 
Ser-119. It is known that phosphatases can function as oncogenes or tumor suppressors. Phosphatases can mod-
ulate a variety of signaling pathways, and dysregulation results in abnormal processes including uncontrolled 
proliferation, differentiation, angiogenesis, and metastasis. Therefore, many phosphatases have been associated 
with the development and progression of different types of cancer26. A549 lung cancer cell line was used as a 
model for cell signaling data and xenograft to demonstrate the PDCD5-p53 signaling pathway efficiently because 
A549 and HCT116 cell lines are suitable cell line to highlight PPEF1-PDCD5-p53 pathway. We also used HCT116 
colorectal cancer cell line not only for immunoprecipitation, but for validating PPEF-1 mediated destabilization 
of PDCD5 since A549 and HCT116 cells were well established cell lines to see PDCD5-p53 signaling pathway. 
For reference, we found elevated level of PPEF-1 in colorectal, breast, prostate, liver, and lung cancer from THE 
HUMAN PROTEIN ATLAS (www.proteinatlas.org) website. Our data from the in vivo xenograft assay indicate 
that PPEF-1 overexpression increased the tumorigenic growth and chemoresistance of A549 cells, suggesting that 
PPEF-1 can act as an oncogene in lung cancer development by preventing cancer cell death. Further elucidation 
of PPEF-1 function in human cancer tumorigenesis will facilitate the development of targeted therapeutics for 
cancer treatment.
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Figure 4. PPEF-1 inhibits p53-mediated genotoxic stress response via negative regulation of PDCD5.  
(a) PPEF-1 inhibits ET-induced p53 activation by PDCD5 dephosphorylation. A549 cells were transfected with 
Flag-tagged PPEF-1 and treated with ET. Cell lysates were immunoblotted with the indicated antibodies.  
(b) PPEF-1 reduces ET-induced p53 target gene expression. Puma and Bax mRNA expression were measured 
by qRT-PCR. (c) PPEF-1 phosphatase activity was necessary to inhibit ET-induced PDCD5 phosphorylation. 
Cells were transfected with Flag-tagged PPEF-1WT or inactive PPEF-1D172N mutant, and treated with ET for 6 h. 
Cell lysates were immunoblotted with the indicated antibodies. (d) PPEF-1 knockdown enhanced PDCD5-p53 
signaling. A549 cells were transfected with siPPEF-1, and cell lysates were immunoblotted with the indicated 
antibodies. (e) PPEF-1 suppresses p53 activation via negative regulation of PDCD5. PDCD5f/f MEF cells were 
infected with cre-Adenovirus for 24 h, and then transfected with siPPEF-1 for 48 h. Immunoblotting was 
performed with the indicated antibodies. Full-length blots are presented in Supplementary Figure 4a-e.
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Methods
Cell culture and reagents. Human lung adenocarcinoma cell line A549 and human colorectal carcinoma 
cell line HCT116 were purchased from and authenticated by the Korean Cell Line Bank (Seoul, Korea) using short 
Figure 5. PPEF-1 overexpression confers chemoresistance in A549 human lung cancer cells. (a) PPEF-1 
overexpression confers resistance to ET-induced cell apoptosis. A549 cells were transfected with either Flag-
PPEF-1 or siRNAs. Cells were treated with ET after 24 h, and cell viability was determined using MTT assays. 
Error bars indicate standard deviation (SD; n = 3). **P < 0.01 versus control. (b) PPEF-1 knockdown increases 
ET-induced apoptosis in A549 cells. A549 cells were transfected with either Flag-PPEF-1 or siRNAs. Cells 
were treated with ET after 24 h and cell apoptosis was measured using TUNEL assays. Error bars indicate 
standard deviation (SD; n = 3). *P < 0.05, **P < 0.01 versus control. (c) PPEF-1 overexpression enhances the 
chemoresistance of A549 cells. PPEF-1 or PPEF-1D172N stable overexpression cells were injected subcutaneously 
into the right flank of nude mice and allowed to grow for 2 weeks. Then, mice with comparable-sized tumors 
(~50 mm3) were selected for treatment with ET (10 mg/kg) at 2-day intervals for 6 weeks. Tumor volumes were 
measured every other day. *P < 0.05, **P < 0.01 versus A549-emp+ ET. Error bars indicate SD (n = 6 per group). 
Full-length blots are presented in Supplementary Figure 5c.
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tandem repeat analysis. A549 cells were cultured in RPMI, and HCT116 and PDCD5f/f MEF cells were cultured in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS), 100 units/
mL penicillin, and 0.1 mg/mL streptomycin (Hyclone, Logan, UT, USA) at 37 °C under 5% CO2. Etoposide, 
MG132, and cycloheximide (CHX) were purchased from Sigma-Aldrich (St. Louis, MO, USA) and prepared in 
dimethyl sulfoxide (DMSO) (Sigma-Aldrich). Lipofectamine 2000 reagent was used for transfection of overex-
pression constructs, and Lipofectamine RNAiMax reagent was used for siRNA transfection (Life Technologies, 
Grand Island, NY, USA).
Plasmids and small interfering RNAs (siRNAs). PPEF-1 and PDCD5 constructs were generated by PCR 
and cloned into the pSG5-KF2M1-FLAG, -Myc, or –HA vectors (Sigma-Aldrich), and the pGEX4T-1 vector (GE 
Healthcare, Piscataway, NJ, USA). All plasmid constructs were verified by DNA sequencing. For siRNA transfection, 
cells were plated at 60–70% confluency and transfected using Lipofectamine RNAiMax (Life Technologies) with 
10 pM siRNA following the manufacturer’s protocol. The medium was changed after 4 h, cells were incubated for 
2 days, and then treated with the indicated reagents. The following siRNA sequences were used: for siPPEF-1 #1, sense 
5′ -CACAUAUGAUUUAGAUAGAUU-3′ and antisense 5′ -UCUAUCUAAAUCAUAUGUGUU-3′ ; for 
siPPEF-1 #2, sense 5′ -GCAUUAGUACCUACAUAUUUU-3′ and antisense 5′ -AAUAUGUAGGUACUAAUG 
CUU-3′ ; for siPPEF-1 #3, sense 5′ -GAAGCAUUGACUUUAAUGAUU-3′ and antisense 5′ -UCAUUAAAGUCAA 
UGCUUCUU-3′ ; for negative control, sense 5′ -CCUCGUGCCGUUCCAUCAGGUAGUU-3′ and antisense 
5′ -CUACCUGAUGGAACGGCACGAGGUU-3′ .
Site-directed mutagenesis. Various mutants were created using the QuickChange kit (Agilent 
Technologies, Santa Clara, CA, USA). Site-directed mutagenesis was performed with 18 PCR amplification cycles 
under the following reaction conditions: denaturation at 94 °C for 30 s, annealing at 55 °C for 1 min, and exten-
sion at 68 °C for 10 min. Amplified mixtures were treated with DpnI (Agilent Technologies) at 37 °C for 1 h, and 
aliquots were used to transform competent E. coli. All constructs were confirmed by DNA sequencing.
Western blotting, immunoprecipitation, and antibodies. Cells were washed with cold 
phosphate-buffered saline (PBS) and collected. Cell extracts were prepared with lysis buffer (50 mmol/L Tris-Cl 
pH 7.5, 150 mmol/L NaCl, 1% NP40, 10 mmol/L NaF, 10 mmol/L sodium pyrophosphate, and protease inhibitors) 
and incubated on ice for 30 min. The lysates were centrifuged at 20,000 × g for 10 min at 4 °C. Total cell lysate pro-
tein was incubated with anti-Myc (Cell Signaling) or anti-Flag (Sigma) antibodies and 20 μ L of protein A/G aga-
rose overnight at 4 °C. Then, the agarose beads were washed with buffer three times, and the immunoprecipitated 
protein-antibody complexes were separated on SDS-PAGE gel and then transferred to nitrocellulose membranes. 
The membranes were blocked by incubating for 2 h in 5% (w/v) non-fat DifcoTM skim milk blocking buffer in 
1× PBS with Tween-20 (PBST). The blocked membranes were incubated overnight at 4 °C with the indicated anti-
bodies. The membranes were then washed with 1× PBST, incubated with the appropriate secondary anti-rabbit 
or anti-mouse horseradish peroxidase-conjugated antibody (Thermo Scientific, Rockford, IL, USA) for 1 h, and 
visualized using the LAS-3000 system (Fujifilm, Stamford, CT, USA) with an enhanced chemiluminescence 
detection reagent (Thermo Scientific). The following antibodies were used: anti-phospho PDCD5S119 (generated 
by AbFrontier, Seoul, South Korea), anti-PDCD5 (Proteintech, Chicago, IL, USA), anti-PPEF-1 and anti-HA 
(Santa Cruz Biotechnology, Dallas, Texas, USA), anti-Flag and anti-β -actin (Sigma-Aldrich), and anti-Myc (Cell 
Signaling, Danvers, MA, USA).
RNA isolation and quantitative RT-PCR. Total RNA was extracted using the TRIzol reagent follow-
ing the standard protocol (TAKARA, Shimogyo-ku, Kyoto, Japan). Then, cDNA was prepared using random 
hexamer primers (Chromogen, Seoul, Korea). PCR was performed using the following forward and reverse 
primers: human GAPDH, 5′ -GATGGCATGGACTGTGGTCA-3′ and 5′ -GCAATGCCTCCTGCACCACC-3′ ; 
human PPEF-1, 5′ -GGCCAAATGCAGTTATCCAC-3′ and 5′ -TCTACTTTGCCAGCAAACTGGTGC-3′ ; 
human PDCD5, 5′ -AAAGCACAGGGAAGCAGAAA-3′ and 5′ -TTGTCCATATCTTGCCATCTG-3′ ; human 
BAX, 5′ -TCTACTTTGCCAGCAAACTGGTGC-3′ and 5′ -TGTCCAGCCCATGATGGTTCTGAT-3′ ; 
5′ -GTGTTCCTACCCCCAATGTGT-3′ . The cDNA concentration was normalized using GAPDH. 
Quantitative-PCR analyses were performed using SYBR Green PCR master mix reagents and an ABI Prism 7700 
sequence detection system (Applied Biosystems, Carlsbad, CA, USA). All reactions were performed in triplicate. 
Relative expression levels and SD values were calculated using the comparative method.
In vivo ubiquitination assay. HCT116 cells were co-transfected with plasmids encoding HA-Ub, 
Myc-PDCD5, Myc-CK2α , or Flag-PPEF1. After 48 h, whole-cell lysates were treated with MG132 for 6 h, and 
subsequently processed for immunoprecipitation with anti-Myc antibody. Ubiquitination of Myc-PDCD5 was 
visualized by western blotting with an anti-HA antibody.
Immunofluorescence staining. Cells were cultured on coverslips, fixed in 4% paraformaldehyde for 
30 min at 4 °C, and then treated with 0.4% Triton X-100 in PBS for 10 min at room temperature. Then, the fixed 
and permeabilized cells were incubated with anti-PDCD5 (Proteintech), anti-Myc (Cell Signaling), or anti-Flag 
(Sigma) antibodies at 37 °C for 2 h, and then stained with goat anti-rabbit FITC or goat anti-mouse rhodamine 
(Invitrogen) at 37 °C for 1.5 h. The nucleus was revealed with Hoechst 33258 staining. Cells were imaged using a 
Zeiss LSM700 confocal microscope (Carl Zeiss, Oberkochen, Germany).
MTT assay. Cell viability was determined with the conventional MTT reduction assay. First, 5 × 103 to 1 × 104 
cells were seeded in a 96-well plate and incubated overnight. Then, cells were transfected with the indicated 
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plasmids for 30 h, and then treated with EGF or gefitinib for another 48 h. Cells were then treated with 15 μ M 
MTT solution (Sigma-Aldrich) for 90 min at 37 °C. Formazan formation was resolved with DMSO solution for 
30 min with shaking. The absorbance was recorded at 570 nm, and a reference was recorded at 630 nm with a 
microplate reader (Model 550, Bio-Rad Laboratories, Hercules, CA, USA).
TUNEL assay. To detect cell apoptosis, DNA fragmentation was evaluated by performing a TUNEL assay 
using the HT Titer TACS Assay Kit (Trevigen, Gaithersburg, MD, USA) according to the manufacturer’s instruc-
tions. Briefly, the cells were fixed with 3.7% buffered formaldehyde solution for 7 min, washed with PBS, permea-
bilized with 100% methanol for 20 min, washed with PBS twice, digested with proteinase K for 15 min, quenched 
with 3% hydrogen peroxide, washed with distilled water, labeled with deoxynucleotidyl transferase, incubated at 
37 °C for 90 min, and then treated with stop buffer. The cells were incubated with TACS-Sapphire substrate, and 
the colorimetric reaction was stopped with 0.2 N HCl after 30 min. The colorimetric reaction was measured in a 
microplate reader at absorbance 450 nm.
Xenograft experiments. A suspension of 106 A549 cells in 100 μ L RPMI with Matrigel matrix (BD Science, 
Lexington, KY, USA) was injected subcutaneously into the left flank of 5-week-old male athymic BALB/c nu/nu 
mice (Orient, Seoul, Korea). Each experimental group included eight mice. Tumor size was monitored closely and 
measured every 2 days using a caliper. Two weeks after injection, mice with comparable-sized tumors (~50 mm3) 
were selected for treatment with ET (10 mg/kg) at 2-day intervals for 5 weeks. After 6 weeks of ET treatment, mice 
were sacrificed, and tumors were harvested, photographed, and weighed. Tumor volume was estimated using the 
formula: Volume = ½ × a × b2, where a and b represent the largest and smallest tumor diameters, respectively. 
Animal studies were performed in accordance with the National Institutes of Health guidelines and ethics guide-
lines of Yonsei University, and all animal procedures were approved by the Committee on Animal Investigations 
of Yonsei University and complied with the animal welfare act. The methods applied in this study were performed 
in accordance with the approved guidelines.
Statistical analysis. Statistical significance was examined using Student’s t-test. The two-tailed t-test was 
used for comparisons of two groups. Values were reported as mean ± standard deviation (SD). P values < 0.05 
were considered significant.
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